Sanofi, Teva's RELIEVE UCCD Phase 2b Study Meets P...
Category : Clinical Trial Update 20 December 2024Sanofi and Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd., announced th...
Clinical Trial Update
Bayer's Phase III QUASAR Study: Positive Results f...
Category : Clinical Trial Update 20 December 2024Bayer announced positive topline results from the global phase III QUASAR study evaluating the effic...
Larimar Reports Positive OLE Data, Advances Nomlab...
Category : Clinical Trial Update 19 December 2024Larimar Therapeutics, Inc., a clinical-stage biotechnology company focused on developing treatments...
Menarini Reports Positive Phase 3 Results for Obic...
Category : Clinical Trial Update 19 December 2024Menarini Group announces positive topline data from the phase 3 BROADWAY (NCT05142722) and the phase...
MannKind Reports Phase 3 INHALE-1 Results for Afre...
Category : Clinical Trial Update 19 December 2024MannKind Corporation, a company focused on the development and commercialization of inhaled therapeu...
Latest Newsletter Post
-
TRYNGOLZA™ (olezarsen) Approved in..
20 December 2024
-
Sanofi, Teva's RELIEVE UCCD Phase 2..
20 December 2024
-
Bayer's Phase III QUASAR Study: Pos..
20 December 2024
-
FDA Fast-Tracks Lipocine’s LPCN 114..
20 December 2024
-
MannKind Reports Phase 3 INHALE-1 R..
19 December 2024
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com